🇺🇸 FDA

Drug profile · INN

pandemic influenza vaccine (h5n1) (surface antigen, inactivated, adjuvanted, prepared in cell cultures)

INCELLIPAN

J07BB02
Patents linked
0
News articles
0

Quick answer

pandemic influenza vaccine (h5n1) (surface antigen, inactivated, adjuvanted, prepared in cell cultures) (INCELLIPAN) is an FDA-listed pharmaceutical active ingredient.

Key facts

INN pandemic influenza vaccine (h5n1) (surface antigen, inactivated, adjuvanted, prepared in cell cultures)
Brand INCELLIPAN
ATC code J07BB02

Frequently asked questions

What is pandemic influenza vaccine (h5n1) (surface antigen, inactivated, adjuvanted, prepared in cell cultures)?

pandemic influenza vaccine (h5n1) (surface antigen, inactivated, adjuvanted, prepared in cell cultures) (INCELLIPAN) is an FDA-listed pharmaceutical active ingredient.

What is the brand name for pandemic influenza vaccine (h5n1) (surface antigen, inactivated, adjuvanted, prepared in cell cultures)?

INCELLIPAN is a marketed brand name for pandemic influenza vaccine (h5n1) (surface antigen, inactivated, adjuvanted, prepared in cell cultures). Check FDA Drugs@FDA for the current US label holder and prescribing information.